Skip to main content

Message from the Chair

Welcome to the Department of Cardiovascular Medicine at the University of Kansas Medical Center. Over the past decade, our Department has experienced phenomenal growth in both the clinical and research enterprise - and consistent with this growth, the Department of Cardiovascular Medicine at the University of Kansas Hospital has been ranked in the top 50 programs in the nation for 12 consecutive years by the U.S. News & World Report's annual survey. We are ranked the top cardiology program in the Kansas City metro region as well as top hospital in Kansas City and the State of Kansas! We have a strong commitment to patient care, education and contributing to our profession through research.

The University of Kansas Hospital is the largest academic tertiary care center in the region catering to more than 2 million people in Kansas and several adjoining states. Our internationally recognized cardiovascular physicians deliver the highest standards of patient care in all cardiovascular subspecialties, including cutting edge interventional and device therapies for coronary artery disease, cardiac rhythm disorders, and heart failure. We have a comprehensive structural cardiology program which is built on a strong collaboration with our surgical colleagues. We have exceeded 1000 TAVR and 150 Mitraclip procedures. Additionally, we are the first in the region to offer TMVR as part of the APOLLO trial. We have seen tremendous growth in our VAD and Transplant program with some of the best outcomes in the nation. Indeed, very few programs in the country provide such an extensive array of cardiovascular therapies. Our excellence in clinical cardiovascular care is reflected in very high patient satisfaction and very low mortality.

Our teaching efforts are continuously monitored and improved. In addition to Dr. David Wilson, M.D., who has served for many years as the general cardiovascular fellowship Program Director, we have recently appointed Associate Program Directors to shape and enhance fellow education in specific subspecialty areas in the ever-changing frontiers of cardiovascular therapy. Based on high volume and patient complexities, advanced fellowships are also offered in interventional cardiology and electrophysiology. A well-balanced conference series is used as the primary vehicle for didactic teaching. A number of lectures by invited speakers are also available to enhance understanding of complex cardiovascular disease processes and molecular pathobiology.

In the research arena, we strive to build new knowledge and translate the existing into therapeutic practices for improved patient care in the future. The newly formed Center for Cardiovascular and Cardiothoracic Research is a tribute to our strong partnership with surgical colleagues and offers a platform for a strong clinical trials program. Our basic science program offers opportunities to bring clinicians and basic scientists together, promoting translation. Over the past years, research conducted by our fellows and faculty has resulted in numerous presentations, publications, and funded clinical trials. The multicenter clinical trials also provide the opportunity for patients to utilize innovative therapies and devices that are otherwise unavailable.

This is only the beginning. We are continuously developing novel plans for the expansion of patient care, training the future leaders in cardiology, and conquering the unknown through trailblazing research. In the coming years, we will work hard, together, to grow our program to loftier heights.

Thank you for visiting...and we hope you will join us in this exciting venture!

Last modified: Feb 05, 2019

Mark Wiley

Mark A. Wiley, MD, FACC, FSCAI
Professor and Chair
Department of Cardiovascular Medicine

ID=x2707